EastWest Bioscience Inc.
HBOSF · OTC
4/30/2022 | |
|---|---|
| Market Cap | $1,851 |
| - Cash | $16 |
| + Debt | $1,910 |
| Enterprise Value | $3,745 |
| Revenue | $200 |
| % Growth | – |
| Gross Profit | $144 |
| % Margin | 71.9% |
| EBITDA | -$390 |
| % Margin | -195.2% |
| Net Income | -$436 |
| % Margin | -218.2% |
| EPS Diluted | -0.004 |
| % Growth | – |
| Operating Cash Flow | -$3 |
| Capital Expenditures | $0 |
| Free Cash Flow | -$3 |